Singapore markets closed

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
138.71-1.58 (-1.13%)
As of 10:51AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 253.42B
Enterprise value 316.39B
Trailing P/E 20.27
Forward P/E 12.30
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.44
Price/book (mrq)17.29
Enterprise value/revenue 5.52
Enterprise value/EBITDA 12.88

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 326.18%
S&P500 52-week change 3-14.73%
52-week high 3175.91
52-week low 3106.86
50-day moving average 3140.51
200-day moving average 3146.49

Share statistics

Avg vol (3-month) 35.53M
Avg vol (10-day) 36.71M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.75%
Shares short (14 Sept 2022) 412.95M
Short ratio (14 Sept 2022) 42.93
Short % of float (14 Sept 2022) 40.73%
Short % of shares outstanding (14 Sept 2022) 40.73%
Shares short (prior month 14 Aug 2022) 413.01M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 44.20%
Trailing annual dividend rate 35.53
Trailing annual dividend yield 33.94%
5-year average dividend yield 44.31
Payout ratio 476.66%
Dividend date 314 Nov 2022
Ex-dividend date 412 Oct 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 22.03%
Operating margin (ttm)33.06%

Management effectiveness

Return on assets (ttm)8.14%
Return on equity (ttm)92.71%

Income statement

Revenue (ttm)57.35B
Revenue per share (ttm)32.39
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)38.88B
EBITDA 27.17B
Net income avi to common (ttm)12.57B
Diluted EPS (ttm)7.07
Quarterly earnings growth (yoy)20.60%

Balance sheet

Total cash (mrq)9.96B
Total cash per share (mrq)5.64
Total debt (mrq)73.19B
Total debt/equity (mrq)498.28
Current ratio (mrq)0.84
Book value per share (mrq)8.29

Cash flow statement

Operating cash flow (ttm)22.92B
Levered free cash flow (ttm)18.63B